Charlotte C. Ruiten

Effect of exenatide twice daily and dapagliflozin, alone and in combination, on markers of kidney function in obese patients with type 2 diabetes: A prespecified secondary analysis of a randomized controlled clinical trial

M. Nieuwdorp, H. Heerspink, R. IJzerman, 2021, Diabetes, obesity & metabolism.